Βιβλιογραφική Τεκμηρίωση:
Peginterferon alfa-2a is superior to peginterferon alfa-2b in the treatment of naive patients with hepatitis C virus infection: meta-analysis of randomized controlled trials. Singal AK, Jampana SC, Anand BS.Dig Dis Sci. 2011 Aug;56(8):2221-6.
Peginterferon alfa-2b or alfa-2a with ribavirin for treatment of hepatitis C infection.McHutchison JG, Lawitz EJ, Shiffman ML, Muir AJ, Galler GW, McCone J, Nyberg LM, Lee WM, Ghalib RH, Schiff ER, Galati JS, Bacon BR, Davis MN, Mukhopadhyay P, Koury K, Noviello S, Pedicone LD, Brass CA, Albrecht JK, Sulkowski MS; IDEAL Study Team.N Engl J Med. 2009 Aug 6;361(6):580-93.
Peginterferon alfa-2a and peginterferon alfa-2b combined with ribavirin in patients with genotype 1 chronic hepatitis C: results of a prospective single-centre study.Berak H, Laskus T, Kołakowska-Rządzka A, Wasilewski M, Stańczak JJ, Bardadin K, Walewska-Zielecka B, Horban A.Adv Med Sci. 2014 Sep;59(2):261-5.
peginterferon alfa-2b
